Rapid Dose Therapeutics Appoints Dr. Michael Glogauer to Advisory Board

CANNANNEW REPORT

BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is pleased to announce another significant addition to the Company’s advisory board with the appointment of Dr. Michael Glogauer. Dr. Glogauer is the Dentist in Chief at the University Health Network and Princess Margaret Cancer Centre and a Full Professor in the Faculty of Dentistry at the University of Toronto. His keen interest in research makes Dr. Glogauer the ideal Scientific Director at the Centre for Advanced Dental Research and Care at Mt. Sinai Hospital and the Chief Scientific Officer and Founder of Ostia Sciences Inc. “The addition of Dr. Glogauer to the RDT Advisory Board provides a unique opportunity to collaborate with one of Canada’s preeminent leaders in oral and dental care where he will be looked upon to provide guidance into ongoing innovation of our sublingual technology,” said Mark Upsdell, CEO, Rapid Dose Therapeutics. The Company is announcing the granting of incentive stock options to Dr. Glogauer to purchase, in total, 200,000] common shares at an exercise price of $.51 per share. The options vest equally every six months over a two-year period and expire on January 5, 2027. About Rapid Dose Therapeutics Corp. Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. The Company’s flagship product QuickStrip™ is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient. http://www.rapid-dose.com CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release may contain forward-looking information within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact…

Excerpt only …
READ MORE BELOW
Source : Rapid Dose Therapeutics Appoints Dr. Michael Glogauer to Advisory Board

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.